Davis Todd C bought PTHS
July 2, 2025 · Form 4 insider transaction
Davis Todd C bought 19,108 shares of Pelthos Therapeutics Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,108
Price
N/A
Total value
N/A
InsiderDavis Todd C
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJuly 2, 2025
Filing dateJuly 7, 2025
Shares owned after36,969
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 19,108 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis over a period of three (3) years.; The numbers reported herein have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025.